Risk factors for deterioration of renal function after percutaneous nephrolithotomy in solitary kidney patients with staghorn calculi.
Percutaneous nephrolithotomy (PCNL)
renal function
risk factors
solitary kidney
staghorn calculi
Journal
Translational andrology and urology
ISSN: 2223-4691
Titre abrégé: Transl Androl Urol
Pays: China
ID NLM: 101581119
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
entrez:
19
11
2020
pubmed:
20
11
2020
medline:
20
11
2020
Statut:
ppublish
Résumé
Nowadays, it has not been reported in detail which factors have adverse effects on renal function after PNCL surgery in solitary kidney patients with staghorn calculi. To evaluate the risk factors that deteriorate the renal function in solitary kidney patients with staghorn calculi after percutaneous nephrolithotomy (PCNL). A retrospective study was performed on solitary kidney patients with staghorn calculi between March 2014 and Jun 2019. Renal function-related indexes were collected pre-operatively, and at 1 and 6 months post-operatively. These pre- and post-operative indexes were compared to study the risk factors on renal function. Totally 71 solitary kidney patients with staghorn calculi were included with a male-to-female ratio of 53:18 and mean age of 54.3±10.2 years old. The mean pre-operative estimated glomerular filtration rate (eGFR) and serum creatinine were 55.1±18.9 mL/min/1.73 m Preoperative UTI can deteriorate the renal function at 1 month after PCNL, and diabetes can deteriorate the postoperative renal function at 6 months after PCNL. Controlled perioperative UTI, diabetes and factors play a crucial role in protecting renal function after PCNL for solitary kidney patients with staghorn calculi.
Sections du résumé
BACKGROUND
BACKGROUND
Nowadays, it has not been reported in detail which factors have adverse effects on renal function after PNCL surgery in solitary kidney patients with staghorn calculi. To evaluate the risk factors that deteriorate the renal function in solitary kidney patients with staghorn calculi after percutaneous nephrolithotomy (PCNL).
METHODS
METHODS
A retrospective study was performed on solitary kidney patients with staghorn calculi between March 2014 and Jun 2019. Renal function-related indexes were collected pre-operatively, and at 1 and 6 months post-operatively. These pre- and post-operative indexes were compared to study the risk factors on renal function.
RESULTS
RESULTS
Totally 71 solitary kidney patients with staghorn calculi were included with a male-to-female ratio of 53:18 and mean age of 54.3±10.2 years old. The mean pre-operative estimated glomerular filtration rate (eGFR) and serum creatinine were 55.1±18.9 mL/min/1.73 m
CONCLUSIONS
CONCLUSIONS
Preoperative UTI can deteriorate the renal function at 1 month after PCNL, and diabetes can deteriorate the postoperative renal function at 6 months after PCNL. Controlled perioperative UTI, diabetes and factors play a crucial role in protecting renal function after PCNL for solitary kidney patients with staghorn calculi.
Identifiants
pubmed: 33209666
doi: 10.21037/tau-20-916
pii: tau-09-05-2022
pmc: PMC7658125
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2022-2030Informations de copyright
2020 Translational Andrology and Urology. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tau-20-916). The authors have no conflicts of interest to declare.
Références
Circ Res. 2019 Apr 12;124(8):1166-1168
pubmed: 30973815
Br J Cancer. 2019 Feb;120(3):368-374
pubmed: 30563989
Immunity. 2019 Oct 15;51(4):596-598
pubmed: 31618649
Eur Urol. 2016 Mar;69(3):468-74
pubmed: 26318710
Aging Male. 2020 Jan 3;:1-7
pubmed: 31900026
BJU Int. 2012 Dec;110(11 Pt C):E1022-6
pubmed: 22540846
Mult Scler Relat Disord. 2020 May;40:101987
pubmed: 32062442
JAMA Surg. 2020 Mar 1;155(3):e195472
pubmed: 31968070
BMC Urol. 2017 Jan 18;17(1):9
pubmed: 28100225
Eur Urol. 2019 Sep;76(3):398-403
pubmed: 31080127
Antimicrob Agents Chemother. 2020 Mar 24;64(4):
pubmed: 31932371
Mult Scler. 2017 Feb;23(2):277-285
pubmed: 27230791